Lyra Therapeutics (LYRA) Shares Issued (2019 - 2025)
Lyra Therapeutics (LYRA) recorded quarterly Shares Issued of $68539.0 in Q4 2025, little changed on a QoQ basis from $68558.0 in Q3 2025, and down 45.71% YoY from $126255.0 in Q4 2024.
Lyra Therapeutics (LYRA) Shares Issued (2019 - 2025) Analysis & Trends
Lyra Therapeutics (LYRA) has reported Shares Issued for 7 consecutive years, with $68539.0 the latest figure, recorded in Q4 2025.
- Shares Issued for Q4 2025 came in at $68539.0, down 45.71% year-over-year; the trailing twelve-month figure through Dec 2025 was $68539.0 (down 45.71% YoY), and the FY2025 annual result was $68539.0, down 45.71% from the prior year.
- Shares Issued for Q4 2025 stood at $68539.0, roughly flat from $68558.0 in the prior quarter.
- The five-year high for Shares Issued was $8.1 million in Q1 2024, with the low at $68539.0 in Q4 2025.
- A 5-year average of $3.4 million and a median of $3.5 million in 2022 frame the typical range for Shares Issued.
- Across the five-year window, Shares Issued surged 368.63% in 2023 and slumped 98.93% in 2025, its largest moves.
- Lyra Therapeutics' Shares Issued stood at $1.7 million in 2021, then surged by 159.27% to $4.3 million in 2022, then soared by 32.44% to $5.7 million in 2023, then tumbled by 97.79% to $126255.0 in 2024, then sank by 45.71% to $68539.0 in 2025.
- The last three Shares Issued figures came in at $68539.0 (Q4 2025), $68558.0 (Q3 2025), and $89959.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Lyra Therapeutics | 70,995.28 | 70,995.28 | - | 68,539.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 68,539.00 |
| Dec 31, 2025 | 68,539.00 |
| Sep 30, 2025 | 68,558.00 |
| Sep 30, 2025 | 68,558.00 |
| Jun 30, 2025 | 89,959.00 |
| Jun 30, 2025 | 89,959.00 |
| Mar 31, 2025 | 4.51 Mn |
| Mar 31, 2025 | 4.51 Mn |
| Dec 31, 2024 | 126,255.00 |
| Dec 31, 2024 | 126,255.00 |
| Sep 30, 2024 | 6.39 Mn |
| Sep 30, 2024 | 6.39 Mn |
| Jun 30, 2024 | 7.05 Mn |
| Jun 30, 2024 | 7.05 Mn |
| Mar 31, 2024 | 8.05 Mn |
| Mar 31, 2024 | 8.05 Mn |
| Dec 31, 2023 | 5.71 Mn |
| Dec 31, 2023 | 5.71 Mn |
| Sep 30, 2023 | 5.84 Mn |
| Sep 30, 2023 | 5.84 Mn |